Phytochemical Bioavailability and Metabolism

Bioavailability is the fraction of an ingested phytochemical that reaches the circulation in an active form; metabolism is the set of transformations — in the gut, liver, and tissues — that act on these compounds along the way. Together they determine which molecules actually reach target tissues, often differing markedly from the parent compounds present in food.

Definition

Phytochemical bioavailability and metabolism is the study of how dietary phytochemicals are released from food, absorbed, conjugated, transformed by gut microbiota and host enzymes, distributed, and excreted, and of how these processes shape the concentrations and chemical identities of the compounds reaching tissues.

Scope

This topic covers the determinants of phytochemical absorption (food matrix, chemical form, and solubility), the phase II conjugation and gut-microbial metabolism that generate circulating metabolites, the typically low and variable bioavailability of polyphenols and carotenoids, and the implications for interpreting their biological effects. It is a biochemistry and nutrition reference, not dietary guidance.

Core questions

• What determines how much of a dietary phytochemical is absorbed?
• How do phase II conjugation and gut microbiota transform phytochemicals after ingestion?
• Why are circulating metabolites often different from the parent compounds in food?
• How does bioavailability complicate interpretation of phytochemical health effects?

Key concepts

• Bioavailability and bioefficacy
• Food matrix and release from the food
• Phase II conjugation (glucuronidation, sulfation, methylation)
• Gut microbial metabolism and microbial metabolites
• Enterohepatic recirculation and excretion
• Inter-individual variability

Key theories

Metabolite-driven bioactivity

Because parent phytochemicals are extensively conjugated and metabolised, the compounds that circulate and reach tissues are largely metabolites, so biological activity should be ascribed to these forms rather than to the food-borne parent compound.

Food matrix and microbiome as determinants

Bioavailability depends strongly on the food matrix, chemical form, and gut microbial community, which explains the large inter-individual and inter-food variability in phytochemical exposure.

Mechanisms

After ingestion, phytochemicals must be released from the food matrix before absorption. Many polyphenols are absorbed in the small intestine, where they undergo extensive phase II conjugation — glucuronidation, sulfation, and methylation — so that they circulate chiefly as conjugates rather than free aglycones. A large fraction reaches the colon, where the gut microbiota cleave and transform them into smaller phenolic metabolites that may themselves be absorbed. Lipophilic carotenoids depend on micelle formation and dietary fat for uptake. Conjugates can undergo enterohepatic recirculation, and the resulting plasma concentrations are generally low, transient, and highly variable between individuals and food sources.

Clinical relevance

Bioavailability and metabolism explain why the antioxidant capacity of a phytochemical measured in vitro often predicts its effects in the body poorly, and why responses to phytochemical-rich foods vary between people. The entry is intended to aid interpretation of mechanistic and nutritional evidence and is not a basis for individual dietary or supplement decisions.

Evidence & guidelines

Systematic compilations of human bioavailability studies and mechanistic reviews establish that most dietary phytochemicals reach plasma at low, variable concentrations as metabolites; this is the central reason reviews caution against equating in vitro antioxidant assays with in vivo benefit. No clinical guidance is issued here.

History

Early phytochemical research often assumed parent compounds acted directly, but systematic reviews of human bioavailability from the early 2000s, notably by Manach and colleagues, documented low and variable absorption and extensive metabolism. Growing attention to the gut microbiome then established microbial metabolites as major contributors, reframing how phytochemical bioactivity is understood.

Debates

Which forms of a phytochemical are biologically responsible for observed effects?

Since parent compounds circulate at low levels and are heavily metabolised, debate continues over whether conjugates, microbial metabolites, or transient parent compounds account for the biological effects attributed to phytochemical-rich diets.

Key figures

• Claudine Manach
• Gary Williamson
• Augustine Scalbert
• Alan Crozier
• Robert M. Russell

Seminal works

• manach-2005
• manach-2004
• del-rio-2013

Frequently asked questions

Why do circulating phytochemicals differ from those in food?

After absorption, phytochemicals are conjugated by host enzymes and transformed by gut bacteria, so the molecules found in blood are usually metabolites rather than the original compounds present in the food.

Why is bioavailability important for understanding antioxidant foods?

A compound can only act in tissues if it is absorbed and reaches them; because many phytochemicals are poorly and variably absorbed, their in vitro antioxidant strength does not reliably predict their effects in the body.